UK Leukemia Therapeutics Market Analysis


  • Type: Oncology area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2528

  • Format: PPT, PDF

UK Leukaemia Therapeutics Market: Segmented by Disease Condition (Chronic Lymphatic, Acute Lymphatic, Chronic Myeloid, Acute Myeloid Leukemia), Treatment (Induction Therapy, Consolidation therapy, Maintenance therapy, Biological therapy, Stem cell transplant, Bone marrow transplant Type) & Drugs(Gleevec, Sapacitabine, GA101, Vasaroxine, Tosedosat) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 2528 Categories: ,

Report Overview

UK’s Leukaemia Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX.X% during the forecast period.

Leukaemia is the 12th most common cancer in the UK, accounting for 3% of all new cancer cases. In females in the UK, leukaemia is the 12th most common cancer, with around 4,000 new cases. In males in the UK, leukaemia is the 10th most common cancer, with around 5,800 new cases. Incidence rates for leukaemia in the UK are highest in people aged 85 to 89. Each year almost 4 in 10 (38%) of all new leukaemia cases in the UK are diagnosed in people aged 75 and over. Since the early 1990s, leukaemia incidence rates have increased by a sixth (17%) in the UK. Rates in females have increased by around a seventh (14%) and rates in males have increased by around a seventh (13%).

Market Driving and Restraining Factors

Market Drivers

The market for Leukemia Therapeutics in UK is propelling mainly due to factors like increased innovation and R&D in the oncology sectors and a growing number of biotechnology firms.

As Leukemia cases are more common in adults and are observed to progress with aging, the increase in geriatric population also plays its role in the market growth.

Restraining Factors

Factors like the high cost of drugs and treatments along with many entry-to-market barriers are the major restraining factors for this market.

1. UK Leukaemia Therapeutics Market Overview……………………………
A. Market Size
2. Market Driving and Restraining Factors………………………………….………….
A. Market Drivers
I. Increased innovation and R&D
II. Increasing Geriatric Population
B. Restraining Factors
I. High treatment costs
3. Leukaemia Therapeutics Market Segmentation…………………………………
A. By Disease condition
I. Chronic Lymphatic Leukemia
II. Acute Lymphatic Leukemia
III. Chronic Myeloid Leukemia
IV. Acute Myeloid Leukemia
B. By Treatment
I. Induction Therapy
II. Consolidation therapy
III. Maintenance therapy
IV. Biological therapy
V. Stem cell transplant
VI. Bone marrow transplant
C. By Drugs
I. Gleevec
II. Sapacitabine
III. GA101
IV. Vasaroxine
V. Tosedosat
4. Leukaemia Therapeutics Major Products Market Share………………………
A. Market Analysis, Insights and Forecast – By Revenue
5. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
6. Key Company Profiles…………………………………………………………………..
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Celgene Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
8. Factors Driving Future Growth…………………………………………………………
A. New Trends and Developments
9. Potential Market Opportunities………………………………………..
A. Current Market Opportunities
B. Future Market Opportunities
10. Conclusion

Market Segmentation

Segmentation based on disease condition:

UK Prostate Cancer Market can be segmented based on disease condition as:

  • Chronic Lymphatic Leukemia
  • Acute Lymphatic Leukemia
  • Chronic Myeloid Leukemia
  • Acute Myeloid Leukemia

In UK, about 38 percent of the diagnosed cases were chronic lymphocytic leukaemia (CLL) and about 23 percent acute myeloid leukaemia (AML).

Of the more than 1000 annual cases of acute lymphoblastic leukemia (ALL) in UK, about 45% of the children are below the age of 15 years, while 4100 annual cases of acute myeloid leukemia (AML) mostly occur in higher age groups, with a median age of 72 years at onset. During the last decade, the incidence rates have remained stable. The 5‑year survival is high for children (92% for ALL and 74% for AML) but survival decreases significantly with increasing age at onset.

Based on Treatment:

UK Leukaemia Therapeutics Market can be segmented based on treatment as:

  • Induction Therapy
  • Consolidation therapy
  • Maintenance therapy
  • Biological therapy
  • Stem cell transplant
  • Bone marrow transplant

Stem cell therapy and bone marrow transplant are the emerging trends in the leukemia therapeutics market.

Based on Drugs:

UK Leukaemia Therapeutics Market can be segmented based on drugs as:

  • Gleevec
  • Sapacitabine
  • GA101
  • Vasaroxine
  • Tosedosat

Gleevec was one of the major market growth contributors, in the drugs category.

Major Players

Some of the major players of the UK Prostate Cancer Market are Hoffmann-La Roche Ltd, GlaxoSmithKline Pharmaceuticals Limited, Novartis International AG, Bristol-Myers Squibb, Eisai Co. Ltd, Biogen Idec, Celgene Corporation, Genmab A/S, Cephalon Inc., Clavis Pharma, and Pfizer Inc.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements